Genetic SpA
Genetic SpA is an Italian integrated pharmaceutical company, founded in 2000 and headquartered in Fisciano, focused on the research, development, manufacturing, licensing, and medical devices serving European and adjacent pharma markets.
- Company typePrivate
- Founded2000
- HeadquartersFisciano, Italy
- Headcount101–250
- GTM typeB2B
- OfferingHardware or Manufacturing
What Genetic SpA does
Genetic SpA is an Italian integrated pharmaceutical company headquartered in Fisciano, Italy, founded in 2000 and operating as a private joint-stock company (Società per Azioni) with 101-250 employees. The company's stated scope covers the research, development, manufacturing, and licensing of pharmaceutical products, alongside medical devices, positioning it as a vertically integrated mid-cap European pharma operator rather than a pure R&D biotech or pure generics distributor. Its business model combines proprietary drug/device manufacturing with licensing activities, which typically produces revenue from product sales (domestic and export markets) plus royalty or out-licensing income from partner arrangements. No product-level detail, therapeutic area focus, customer base, geographic footprint, pricing model, or management team information is disclosed in available sources, materially limiting financial and commercial underwriting. The only verifiable external signal is that CVC Capital Partners held a financial stake and divested in November 2025, realizing a 3.2x gross multiple of invested capital and a 25% IRR, suggesting the prior ownership cycle extracted reasonable value but not blockbuster returns relative to top-quartile PE outcomes.
Genetic SpA firmographics
Firmographics- Name
- Genetic SpA
- Website
- https://geneticspa.com
- Company type
- Private
- Founded year
- 2000
- Operating status
- Operating
- Headcount range
- 101–250 employees
- Short description
- Genetic SpA is an Italian integrated pharmaceutical company, founded in 2000 and headquartered in Fisciano, focused on the research, development, manufacturing, licensing, and medical devices serving European and adjacent pharma markets.
- Ownership category
- akta.pro rank
Where Genetic SpA is headquartered
LocationHeadquarters
- HQ city
- Fisciano
- HQ country
- Italy
- HQ region
- Europe
Markets served
Genetic SpA business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Operations, Personnel, Technology or R&D, Supply Chain, Marketing or Sales
Genetic SpA product offering
Product offeringCore offering
Genetic SpA is an integrated pharmaceutical company that conducts pharmaceutical research and development, manufactures pharmaceutical products, licenses drug assets, and produces medical devices. The company spans the full drug-development value chain, from early-stage R&D through commercial manufacturing, and supplements its branded pharmaceutical business with medical device production.
Differentiator
Problem solved
Functional benefit
Companies that use Genetic SpA
Customer profileIdeal customer profiles1 record
Genetic SpA technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Genetic SpA partnerships and signals
Strategic signalRecent moves1 record
Expansion highlights1 record
Genetic SpA competitors and assessment
Company assessmentDirect peers
- Molteni Farmaceutici: Italian pharmaceutical manufacturer with in-house R&D and production of finished dosage forms, directly comparable in scale and integrated manufacturing focus to Genetic SpA.
- DOC Generici: Italian generics-focused pharmaceutical company competing on manufacturing and distribution of finished pharmaceutical preparations, directly overlapping Genetic SpA's manufacturing and licensing activities.
Regional players
- Alfasigma: Italian integrated pharmaceutical company engaged in R&D, manufacturing, and licensing of prescription and OTC products, closely mirroring Genetic SpA's integrated pharma model in the same domestic market.
- Italfarmaco: Italian pharmaceutical group spanning drug R&D, manufacturing, and specialty products, comparable to Genetic SpA as a mid-sized integrated Italian pharma manufacturer.
- Zambon: Italian pharmaceutical multinational focused on respiratory and specialty therapeutics with integrated manufacturing, overlapping Genetic SpA's integrated pharma and manufacturing activities.
- Dompé Farmaceutici: Italian biopharmaceutical company combining R&D and manufacturing of primary-care and biotech products, comparable to Genetic SpA as an integrated Italian pharma firm.
- Rottapharm: Italian pharmaceutical company with R&D, manufacturing, and licensing operations across prescription and consumer health, comparable to Genetic SpA's integrated domestic pharma profile.
Broad incumbents
- Recordati: Large Italian specialty pharma group covering R&D, manufacturing, and licensing across multiple markets; a scaled incumbent overlapping Genetic SpA's integrated model but far broader in reach.
- Menarini: Italy's largest privately held pharmaceutical company with integrated R&D, manufacturing, and global licensing, a broad incumbent in the same national pharma space as Genetic SpA.
- Chiesi Farmaceutici: Italian research-driven pharmaceutical group with strong respiratory and specialty franchises and integrated manufacturing, a larger incumbent operating in Genetic SpA's home market and category.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat3 records
Key risks5 records
Key highlights4 records
Customer concentration
Genetic SpA social profiles
Digital presenceGenetic SpA financial estimates
Financial estimateRevenue estimate
Valuation estimate
Genetic SpA leadership team
Management profileNumber of profiles
Genetic SpA funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Genetic SpA M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Genetic SpA
What does Genetic SpA do?
Genetic SpA is an integrated pharmaceutical company that conducts pharmaceutical research and development, manufactures pharmaceutical products, licenses drug assets, and produces medical devices. The company spans the full drug-development value chain, from early-stage R&D through commercial manufacturing, and supplements its branded pharmaceutical business with medical device production.
Is Genetic SpA a public or private company?
Genetic SpA is a private company. It is classified as private equity controlled and is currently operating.
When was Genetic SpA founded?
Genetic SpA was founded in 2000. It employs 101 to 250 people.
Where is Genetic SpA based?
Genetic SpA is headquartered in Fisciano, Italy, in the Europe region.
Who are Genetic SpA's main competitors?
Direct peers on record are Molteni Farmaceutici and DOC Generici. Regional players are Alfasigma, Italfarmaco, Zambon, Dompé Farmaceutici and Rottapharm. Broad incumbents are Recordati, Menarini and Chiesi Farmaceutici.
Does Genetic SpA have an API?
No public API is recorded for Genetic SpA.